Clinical trial Recruiting at 1 site Observational Ages 19 to 65

How skin and gut microbes change after a burn

Official title: An Exploratory Study on the Dynamics of Microbiome Dysbiosis (Microbial Imbalance) in the Skin and Gut Microbiome of Burn Patients

Run by Hangang Sacred Heart Hospital · NCT07209007 · Data updated 2026-11-12

This study will test whether skin and gut microbes change over two years in adults with healed burns by collecting skin swabs, stool, and clinical measures and comparing them to healthy people.

Quick facts

Study typeObservational
Ages19 Years to 65 Years
SexAll
Enrollment600 (estimated)
SponsorHangang Sacred Heart Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2030
Registry record updatedOctober 6, 2025
Trial IDNCT07209007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19–65 with partial- or full-thickness burns whose wounds have completely healed after debridement, grafting, or conservative treatment and who can provide informed consent.

Probably not a fit

People who used systemic or topical antibiotics, probiotics, steroids, or immunosuppressants within two weeks, who are pregnant or breastfeeding, who have chronic skin diseases or active infections, or who have other medical conditions that make participation inappropriate may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective cohort will follow 600 adults with healed partial- or full-thickness burns and 60 healthy controls, collecting skin swabs from burned scars and matched non-burned sites plus stool samples and clinical measures at baseline, 3, 6, 12, and 24 months. Microbial profiling will be performed using 16S rRNA gene sequencing, and skin physiology (TEWL, hydration, erythema, melanin, elasticity, pH) and blood inflammatory markers (ESR, CRP, IL-6) will be measured. Healthy controls provide single baseline samples for comparison. The study is observational and conducted at Hallym University Hangang Sacred Heart Hospital in Seoul.

Why it matters

Potential benefit: If successful, the results could reveal microbial patterns linked to healing or complications and help guide future monitoring or microbiome-based treatments for burn survivors.

How similar studies have gone: Smaller studies have shown burn-related disruptions in skin or gut microbiomes, but comprehensive long-term paired skin-and-gut profiling at this scale is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Adults aged 19 to 65 years
* Patients with partial- or full-thickness burns whose wounds have completely healed following debridement, grafting, or conservative treatment
* Ability to understand study objectives and provide written informed consent

Exclusion Criteria

* Use of systemic or topical antibiotics, probiotics, steroids, or immunosuppressants within 2 weeks prior to sample collection
* Pregnancy or breastfeeding
* Chronic skin diseases (e.g., psoriasis, eczema) or systemic illnesses affecting the skin microbiome
* Active infections at the sampling site
* Any medical condition judged by the investigator to make participation inappropriate

Where it's running

  • Hallym University Hangang Sacred Heart Hospital
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.